Marker Therapeutics
MRKR
MRKR
56 hedge funds and large institutions have $101M invested in Marker Therapeutics in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.07% less ownership
Funds ownership: 3.43% → 3.36% (-0.07%)
39% less call options, than puts
Call options by funds: $69K | Put options by funds: $114K
Holders
56
Holding in Top 10
1
Calls
$69K
Puts
$114K
Top Buyers
| 1 | +$1.78M | |
| 2 | +$1.17M | |
| 3 | +$868K | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$643K |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
+$548K |
Top Sellers
| 1 | -$8.26M | |
| 2 | -$281K | |
| 3 | -$208K | |
| 4 |
Barclays
London,
United Kingdom
|
-$195K |
| 5 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$72.4K |